Roche Molecular Systems

Roche Molecular Systems, Inc. is a molecular diagnostics company that develops and commercializes diagnostic and blood screening tests based on polymerase chain reaction (PCR) technology. Its products include in vitro diagnostic PCR kits, research assays, and related technology platforms, including options that enable the automation of the PCR process. It provides diagnostic and research assays in the fields of virology, blood screening, women's health, HPV, chlamydia trachomatis, Neisseria gonorrhoeae, microbiology, and genomics, as well as develops tests in the field of oncology. The company also offers PCR-based nucleic acid testing and automation capable of detecting active HIV, hepatitis C, and hepatitis B infections and reducing the transmission of these diseases during transfusions, transplants, or managing other medical therapies derived from blood products. Additionally, it provides clinical laboratory systems that integrate CE-marked in vitro diagnostic tests for chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and human papillomavirus (HPV) with fully automated sample preparation and real-time polymerase chain reaction (PCR) technology.